Sponsorship bias in the comparative efficacy of psychotherapy and pharmacotherapy for adult depression: Meta-analysis

British Journal of Psychiatry

Volumn 210, Issue 1, 2017, Pages 16-23

  Cristea, Ioana A ^a,b   Gentili, Claudio ^b   Pietrini, Pietro ^c   Cuijpers, Pim ^d  

^a BABE BOLYAI UNIVERSITY   (Romania)

^b UNIVERSITY OF PADOVA   (Italy)

^c IMT SCHOOL FOR ADVANCED STUDIES LUCCA   (Italy)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; COMPARATIVE EFFECTIVENESS; CONFLICT OF INTEREST; DRUG INDUSTRY; FUNDING; HUMAN; META ANALYSIS; PSYCHOTHERAPY; DEPRESSIVE DISORDER; ECONOMICS; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ANTIDEPRESSANT AGENT;

ANTIDEPRESSIVE AGENTS; CONFLICT OF INTEREST; DEPRESSIVE DISORDER; DRUG INDUSTRY; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 85009067390     PISSN: 00071250     EISSN: 14721465     Source Type: Journal    
DOI: 10.1192/bjp.bp.115.179275     Document Type: Review

References (72)

1. Bekelman JE, Li Y, Gross CP. Scope and impact of financial conflicts of interest in biomedical research: A systematic review. JAMA 2003; 289: 454-65.
2. Lundh A, Sismondo S, Lexchin J, Busuioc OA, Bero L. Industry sponsorship and research outcome. Cochrane Database Syst Rev 2012; 12: MR000033.
3. Lexchin J, Bero LA, Djulbegovic B, Clark O. Pharmaceutical industry sponsorship and research outcome and quality: Systematic review. BMJ 2003; 326: 1167-70.
4. Thompson DF. Understanding financial conflicts of interest. N Engl J Med 1993; 329: 573-6.
5. Melander H, Ahlqvist-Rastad J, Meijer G, Beermann B. Evidence b(i)ased medicine-selective reporting from studies sponsored by pharmaceutical industry: Review of studies in new drug applications. BMJ 2003; 326: 1171-3.
6. Turner EH, Matthews AM, Linardatos E, Tell RA, Rosenthal R. Selective publication of antidepressant trials and its influence on apparent efficacy. N Engl J Med 2008; 358: 252-60.
7. Gartlehner G, Morgan L, Thieda P, Fleg A. The effect of study sponsorship on a systematically evaluated body of evidence of head-to-head trials was modest: Secondary analysis of a systematic review. J Clin Epidemiol 2010; 63: 117-25.
8. Baker CB, Johnsrud MT, Crismon ML, Rosenheck RA, Woods SW. Quantitative analysis of sponsorship bias in economic studies of antidepressants. Br J Psychiatry 2003; 183: 498-506.
9. Cuijpers P, Sijbrandij M, Koole SL, Andersson G, Beekman AT, Reynolds CF. The efficacy of psychotherapy and pharmacotherapy in treating depressive and anxiety disorders: A meta-analysis of direct comparisons. World Psychiatry 2013; 12: 137-48.
10. Imel ZE, Malterer MB, McKay KM, Wampold BE. A meta-analysis of psychotherapy and medication in unipolar depression and dysthymia. J Affect Disord 2008; 110: 197-206.
11. Cuijpers P, Turner EH, Mohr DC, Hofmann SG, Andersson G, Berking M, et al. Comparison of psychotherapies for adult depression to pill placebo control groups: A meta-analysis. Psychol Med 2014; 44: 685-95.
12. National Institute for Health and Clinical Excellence. Treatment and Management of Depression in Adults, Including Adults with a Chronic Physical Health Problem. NICE, 2009.
13. Cuijpers P, van Straten A, Warmerdam L, Andersson G. Psychological treatment of depression: A meta-analytic database of randomized studies. BMC Psychiatry 2008; 8: 36.
14. Higgins JPT, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011; 343: D5928.
15. Hedges LV, Olkin I. Statistical Methods for Meta-Analysis. Academic Press, 1985.
16. Borenstein M, Hedges LV, Higgins JPT, Rothstein HR. Introduction to Meta-Analysis. Wiley, 2009.
17. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-60.
18. Ioannidis JPA, Patsopoulos NA, Evangelou E. Uncertainty in heterogeneity estimates in meta-analyses. BMJ 2007; 335: 914-6.
19. Orsini N, Bottai M, Higgins J, Buchan I. HETEROGI: Stata Module to Quantify Heterogeneity in a Meta-Analysis. Boston College Department of Economics, 2006 (http://econpapers.repec.org/software/bocbocode/s449201.htm).
20. Duval S, Tweedie R. Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 2000; 56: 455-63.
21. Borenstein M, Hedges LV, Higgins JPT, Rothstein HR. Introduction to Meta-Analysis. Wiley, 2009.
22. Barber JP, Barrett MS, Gallop R, Rynn MA, Rickels K. Short-term dynamic psychotherapy versus pharmacotherapy for major depressive disorder: A randomized, placebo-controlled trial. J Clin Psychiatry 2012; 73: 66-73.
23. Barrett JE, Williams JW, Oxman TE, Frank E, Katon W, Sullivan M, et al. Treatment of dysthymia and minor depression in primary care: A randomized trial in patients aged 18 to 59 years. J Fam Pract 2001; 50: 405-12.
24. Bedi N, Chilvers C, Churchill R, Dewey M, Duggan C, Fielding K, et al. Assessing effectiveness of treatment of depression in primary care. Partially randomised preference trial. Br J Psychiatry 2000; 177: 312-8.
25. Blackburn IM, Moore RG. Controlled acute and follow-up trial of cognitive therapy and pharmacotherapy in out-patients with recurrent depression. Br J Psychiatry 1997; 171: 328-34.
26. Blom MBJ, Jonker K, Dusseldorp E, Spinhoven P, Hoencamp E, Haffmans J, et al. Combination treatment for acute depression is superior only when psychotherapy is added to medication. Psychother Psychosom 2007; 76: 289-97.
27. Browne G, Steiner M, Roberts J, Gafni A, Byrne C, Dunn E, et al. Sertraline and/or interpersonal psychotherapy for patients with dysthymic disorder in primary care: 6-month comparison with longitudinal 2-year follow-up of effectiveness and costs. J Affect Disord 2002; 68: 317-30.
28. David D, Szentagotai A, Lupu V, Cosman D. Rational emotive behavior therapy, cognitive therapy, and medication in the treatment of major depressive disorder: A randomized clinical trial, posttreatment outcomes, and six-month follow-up. J Clin Psychol 2008; 64: 728-46.
29. Dekker JJM, Koelen JA, Van HL, Schoevers RA, Peen J, Hendriksen M, et al. Speed of action: The relative efficacy of short psychodynamic supportive psychotherapy and pharmacotherapy in the first 8 weeks of a treatment algorithm for depression. J Affect Disord 2008; 109: 183-8.
30. DeRubeis RJ, Hollon SD, Amsterdam JD, Shelton RC, Young PR, Salomon RM, et al. Cognitive therapy vs medications in the treatment of moderate to severe depression. Arch Gen Psychiatry 2005; 62: 409-16.
31. Dimidjian S, Hollon SD, Dobson KS, Schmaling KB, Kohlenberg RJ, Addis ME, et al. Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the acute treatment of adults with major depression. J Consult Clin Psychol 2006; 74: 658-70.
32. Dunlop BW, Kelley ME, Mletzko TC, Velasquez CM, Craighead WE, Mayberg HS. Depression beliefs, treatment preference, and outcomes in a randomized trial for major depressive disorder. J Psychiatr Res 2012; 46: 375-81.
33. Dunner DL, Schmaling KB, Hendrickson H, Becker J, Lehman A, Bea C. Cognitive therapy versus fluoxetine in the treatment of dysthymic disorder. Depression 1996; 4: 34-41.
34. Elkin I, Shea MT, Watkins JT, Imber SD, Sotsky SM, Collins JF, et al. National Institute of Mental Health Treatment of Depression Collaborative Research Program. General effectiveness of treatments. Arch Gen Psychiatry 1989; 46: 971-82; discussion 983.
35. Faramarzi M, Alipor A, Esmaelzadeh S, Kheirkhah F, Poladi K, Pash H. Treatment of depression and anxiety in infertile women: Cognitive behavioral therapy versus fluoxetine. J Affect Disord 2008; 108: 159-64.
36. Finkenzeller DW, Zobel I, Rietz S, Schramm E, Berger M. Interpersonelle Psychotherapie und Pharmakotherapie bei Post-Stroke-Depression. Nervenarzt 2009; 80: 805-12.
37. Frank E, Cassano GB, Rucci P, Thompson WK, Kraemer HC, Fagiolini A, et al. Predictors and moderators of time to remission of major depression with interpersonal psychotherapy and SSRI pharmacotherapy. Psychol Med 2011; 41: 151-62.
38. Hegerl U, Hautzinger M, Mergl R, Kohnen R, Schütze M, Scheunemann W, et al. Effects of pharmacotherapy and psychotherapy in depressed primary-care patients: A randomized, controlled trial including a patients' choice arm. Int J Neuropsychopharmacol 2010; 13: 31-44.
39. Hollon SD, DeRubeis RJ, Evans MD, Wiemer MJ, Garvey MJ, Grove WM, et al. Cognitive therapy and pharmacotherapy for depression. Singly and in combination. Arch Gen Psychiatry 1992; 49: 774-81.
40. Jarrett RB, Schaffer M, McIntire D, Witt-Browder A, Kraft D, Risser RC. Treatment of atypical depression with cognitive therapy or phenelzine: A double-blind, placebo-controlled trial. Arch Gen Psychiatry 1999; 56: 431-7.
41. Keller MB, McCullough JP, Klein DN, Arnow B, Dunner DL, Gelenberg AJ, et al. A Comparison of Nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. New Eng J Med 2000; 342: 1462-70.
42. Kennedy SH, Konarski JZ, Segal ZV, Lau MA, Bieling PJ, McIntyre RS, et al. Differences in brain glucose metabolism between responders to CBT and venlafaxine in a 16-week randomized controlled trial. Am J Psychiatry 2007; 164: 778-88.
43. Markowitz JC, Kocsis JH, Bleiberg KL, Christos PJ, Sacks M. A comparative trial of psychotherapy and pharmacotherapy for 'pure' dysthymic patients. J Affect Disord 2005; 89: 167-75.
44. Martin SD, Martin E, Rai SS, Richardson MA, Royall R. Brain blood flow changes in depressed patients treated with interpersonal psychotherapy or venlafaxine hydrochloride: Preliminary findings. Arch Gen Psychiatry 2001; 58: 641-8.
45. McKnight DL, Nelson-Gray RO, Barnhill J. Dexamethasone suppression test and response to cognitive therapy and antidepressant medication. Behavior Therapy 1992; 23: 99-111.
46. McLean PD, Hakstian AR. Clinical depression: Comparative efficacy of outpatient treatments. J Consult Clin Psychol 1979; 47: 818-36.
47. Menchetti M, Rucci P, Bortolotti B, Bombi A, Scocco P, Kraemer HC, et al. Moderators of remission with interpersonal counselling or drug treatment in primary care patients with depression: Randomised controlled trial. Br J Psychiatry 2014; 204: 144-50.
48. Miranda J, Chung JY, Green BL, Krupnick J, Siddique J, Revicki DA, et al. Treating depression in predominantly low-income young minority women: A randomized controlled trial. JAMA 2003; 290: 57-65.
49. Mohr DC, Boudewyn AC, Goodkin DE, Bostrom A, Epstein L. Comparative outcomes for individual cognitive-behavior therapy, supportive-expressive group psychotherapy, and sertraline for the treatment of depression in multiple sclerosis. J Consult Clin Psychol 2001; 69: 942-9.
50. Moradveisi L, Huibers MJH, Renner F, Arasteh M, Arntz A. Behavioural activation v. antidepressant medication for treating depression in Iran: Randomised trial. Br J Psychiatry 2013; 202: 204-11.
51. Murphy GE, Simons AD, Wetzel RD, Lustman PJ. Cognitive therapy and pharmacotherapy. Singly and together in the treatment of depression. Arch Gen Psychiatry 1984; 41: 33-41.
52. Mynors-Wallis LM, Gath DH, Day A, Baker F. Randomised controlled trial of problem solving treatment, antidepressant medication, and combined treatment for major depression in primary care. BMJ 2000; 320: 26-30.
53. Mynors-Wallis LM, Gath DH, Lloyd-Thomas AR, Tomlinson D. Randomised controlled trial comparing problem solving treatment with amitriptyline and placebo for major depression in primary care. BMJ 1995; 310: 441-5.
54. Parker G, Blanch B, Paterson A, Hadzi-Pavlovic D, Sheppard E, Manicavasagar V, et al. The superiority of antidepressant medication to cognitive behavior therapy in melancholic depressed patients: A 12-week single-blind randomized study. Acta Psychiatr Scand 2013; 128: 271-81.
55. Quilty LC, McBride C, Bagby RM. Evidence for the cognitive mediational model of cognitive behavioural therapy for depression. Psychol Med 2008; 38: 1531-41.
56. Rush AJ, Beck AT, Kovacs M, Hollon S. Comparative efficacy of cognitive therapy and pharmacotherapy in the treatment of depressed outpatients. Cogn Ther Res 1977; 1: 17-37.
57. Salminen JK, Karlsson H, Hietala J, Kajander J, Aalto S, Markkula J, et al. Short-term psychodynamic psychotherapy and fluoxetine in major depressive disorder: A randomized comparative study. Psychother Psychosom 2008; 77: 351-7.
58. Schulberg HC, Block MR, Madonia MJ, Scott CP, Rodriguez E, Imber SD, et al. Treating major depression in primary care practice. Eight-month clinical outcomes. Arch Gen Psychiatry 1996; 53: 913-9.
59. Scott AI, Freeman CP. Edinburgh primary care depression study: Treatment outcome, patient satisfaction, and cost after 16 weeks. BMJ 1992; 304: 883-7.
60. Shamsaei F, Rahimi A, Zarabian MK, Sedehi M. Efficacy of pharmacotherapy and cognitive therapy, alone and in combination in major depressive disorder. Hong Kong J Psychiatry 2008; 18: 76.
61. Sharp DJ, Chew-Graham C, Tylee A, Lewis G, Howard L, Anderson I, et al. A pragmatic randomised controlled trial to compare antidepressants with a community-based psychosocial intervention for the treatment of women with postnatal depression: The RESPOND trial. Health Technol Assess 2010; 14: Iii-iv, ix-xi, 1-153.
62. Sloane RB, Staples FR, Schneider LS. Interpersonal therapy vs. nortriptyline for depression in the elderly. In Clinical and Pharmacological Studies in Psychiatric Disorders (ed GD Burrows, TR Norman and L Dennerstein): 344-6. John Libbey, 1985.
63. Thompson LW, Coon DW, Gallagher-Thompson D, Sommer BR, Koin D. Comparison of desipramine and cognitive/behavioral therapy in the treatment of elderly outpatients with mild-to-moderate depression. Am J Geriatr Psychiatry 2001; 9: 225-40.
64. Weissman MM, Prusoff BA, Dimascio A, Neu C, Goklaney M, Klerman GL. The efficacy of drugs and psychotherapy in the treatment of acute depressive episodes. Am J Psychiatry 1979; 136: 555-8.
65. Williams JW, Barrett J, Oxman T, Frank E, Katon W, Sullivan M, et al. Treatment of dysthymia and minor depression in primary care: A randomized controlled trial in older adults. JAMA 2000; 284: 1519-26.
66. Zu S, Xiang Y-T, Liu J, Zhang L, Wang G, Ma X, et al. A comparison of cognitive-behavioral therapy, antidepressants, their combination and standard treatment for Chinese patients with moderate-severe major depressive disorders. J Affect Disord 2014; 152-4: 262-7.
67. Imel ZE, Malterer MB, McKay KM, Wampold BE. A meta-analysis of psychotherapy and medication in unipolar depression and dysthymia. J Affect Disord 2008; 110: 197-206.
68. Cuijpers P, Turner EH, Koole SL, van Dijke A, Smit F. What Is the threshold for a clinically relevant effect?. The case of major depressive disorders. Depress Anxiety 2014; 31: 374-8.
69. Cipriani A, Furukawa TA, Salanti G, Geddes JR, Higgins JP, Churchill R, et al. Comparative efficacy and acceptability of 12 new-generation antidepressants: A multiple-treatments meta-analysis. Lancet 2009; 373: 746-58.
70. Cuijpers P, van Straten A, Andersson G, van Oppen P. Psychotherapy for depression in adults: A meta-analysis of comparative outcome studies. J Consult Clin Psychol 2008; 76: 909-22.
71. Okike K, Kocher MS, Mehlman CT, Bhandari M. Industry-sponsored research. Injury 2008; 39: 666-80.
72. Eisner M, Humphreys DK, Wilson P, Gardner F. Disclosure of financial conflicts of interests in interventions to improve child psychosocial health: A cross-sectional study. PLoS One 2015; 10: E0142803.